Acadia Pharmaceuticals buy Citigroup Inc.
Start price
09.05.24
/
50%
€14.59
Target price
09.05.25
€27.83
Performance (%)
8.26%
End price
10.05.25
€15.80
Summary
This prediction ended on 10.05.25 with a price of €15.80. With a performance of 8.26%, the BUY prediction by Citigroup_Inc_ for Acadia Pharmaceuticals closed with a slight gain. Citigroup_Inc_ has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | -2.676% | -2.676% | -6.419% |
| iShares Core DAX® | 1.119% | -1.545% | 0.672% |
| iShares Nasdaq 100 | 0.352% | 9.674% | 30.509% |
| iShares Nikkei 225® | -1.414% | 2.906% | 42.706% |
| iShares S&P 500 | 0.537% | 4.775% | 20.628% |
Comments by Citigroup_Inc_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.19 to $30.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.40
07.08.25
07.08.25
-
07.08.26
07.08.26
-11.74%
20.05.26
20.05.26
Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.83
08.05.26
08.05.26
€27.29
08.05.27
08.05.27
-6.29%
20.05.26
20.05.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.06
08.08.25
08.08.25
43.94%
09.08.25
09.08.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
13.12.23
13.12.23
€35.17
13.12.24
13.12.24
-17.60%
14.12.24
14.12.24